Topoisomerase II Alpha Gene Amplification and Protein Overexpression Predicting Efficacy of Epirubicin
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Epirubicin
Sponsor: Jules Bordet Institute
Collaborators: Gustave Roussy, Cancer Campus, Grand Paris|Centre Paul Strauss|Centre Hospitalier du Luxembourg|Clinique Louis Cathy - Baudour - Belgium|HIS - Site Etterbeek - Ixelles - Belgium|Clinique Saint Pierre Ottignies|Clinique Ste Elisabeth - Namur - Belgium|University Hospital of Crete|Feculdade de Medicina da Universidade de Sao Paulo - Brasil